Complement C3 and C4, but not their regulators or activated products, are associated with incident metabolic syndrome: the CODAM study

Ying Xin, Elisabeth Hertle, Carla J. H. van der Kallen, Casper G. Schalkwijk, Coen D. A. Stehouwer, Marleen M. J. van Greevenbroek*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)617-627
Number of pages11
JournalEndocrine
Volume62
Issue number3
DOIs
Publication statusPublished - Dec 2018

Keywords

  • Human
  • Complement activation
  • Metabolic syndrome
  • Incidence
  • Longitudinal
  • ACYLATION-STIMULATING PROTEIN
  • ADIPOSE-TISSUE
  • INFLAMMATORY MARKERS
  • INSULIN-RESISTANCE
  • REACTIVE PROTEIN
  • SYSTEM
  • RISK
  • ATHEROSCLEROSIS
  • COMPONENTS
  • EFFECTOR

Cite this